Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
Denis Angioletti
BRD | Director/Board Member | 58 | 2019-12-31 |
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| -1.60% | +1.37% | +57.31% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.64% | +65.40% | 643B | |
| -0.75% | +0.44% | +34.70% | +86.52% | 450B | |
| -1.35% | +0.63% | +30.26% | +26.28% | 336B | |
| -0.86% | +0.99% | +39.36% | +40.85% | 298B | |
| -0.71% | -0.54% | +28.98% | +48.27% | 288B | |
| -1.31% | +2.72% | -26.76% | -39.82% | 222B | |
| -0.03% | +1.62% | +25.62% | +68.30% | 199B | |
| -0.40% | +7.50% | +21.51% | +82.50% | 169B | |
| Average | -5.58% | +2.47% | +31.18% | +60.81% | 411.78B | |
| Weighted average by Cap. | -0.16% | +2.14% | +42.25% | +86.55% |
Employees
4
Sector
Pharmaceuticals
Choose MarketScreener 
